Diuretic side effects;NEBENWIRKUNGEN DER DIURETIKA

Nieren- und Hochdruckkrankheiten

Volumn 25, Issue 4, 1996, Pages 184-191

  Knauf, H ^a  

^a St Bernward Krankenhaus ^*  (Germany)

Author keywords

dose dependency; glucose intolerance; gout; gynecomastia; hypercholesterolemia; hyperkalemia; hypokalemia; hypomagnesemia; hyponatremia; impotence; side effects

Indexed keywords

DIURETIC AGENT; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ALLERGIC REACTION; ARTICLE; DIURESIS; DOSE RESPONSE; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; IMPOTENCE; PANCREATITIS;

EID: 0029893385     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Amery A., P. Berthaux, C. Bulpitt et al.: Glucose intolerance during diuretic therapy. Lancet 1, 681-683 (1978).
2. Ames R.P., P. Hill: Elevation of serum lipid levels during diuretic therapy of hypertension. Am. J. Med. 61, 748-757 (1976).
3. Ames R.P.: Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: possible alternative therapies. Am. J. Cardiol. 51, 632-638 (1983).
4. Ames R.P., P.B. Peacock: Serum cholesterol during treatment of hypertension with diuretic drugs. Arch. Intern. Med. 144, 710-714 (1984).
5. Anonymous: Routine use of potassium-sparing diuretics. Drugs Ther. Bull. 29, 85-87 (1991).
6. Araoye M.A., M.Y. Chang, I.M. Khatri, E.D. Freis: Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension. JAMA 240, 1863-1866 (1978).
7. Ashouri O.S.: Severe diuretic-induced hyponatremia in the elderly. A series of eight patients. Arch. Intern. Med. 146, 1355-1357 (1986).
8. Ashraf N., R. Locksley, A.I. Arieff: Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am. J. Med. 70, 1163-1168 (1981).
9. Berglund G., O. Andersson: Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects. Lancet 1, 744-747 (1981).
10. Breslau N., A.M. Moses, J.M. Weiner: The role of volume contraction in the hypocalciuric action of chlorothiazide. Kidney Int. 10, 164-170 (1976).
11. Cannon P.J., H.O. Heinemann, W.B. Stason, J.H. Laragh: Ethacrynic acid: Effectiveness and mode of diuretic action. Circulation 31, 5-18 (1965).
12. Cannon P.J., H.O. Heinemann, M.S. Albert. J.H. Laragh, R.W. Winters: "Contraction" alkalosis after diuresis of edematous patients with ethacrynic acid. Ann. Intern. Med. 90, 979-990 (1965).
13. Carlsen J.E., L. Köber, C. Torp-Pedersen, P. Johannsen: Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 300, 975-978 (1990).
14. Cohen J.D., J.D. Neaton, R.J. Prineas, K.A. Daniels: Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am. J. Cardiol. 60, 548-554 (1987).
15. Collins R., R. Peto, S. MacMahon, P. Herbert, N.H. Fiebach, I.C.A. Eberline et al.: Blood pressure, stroke, and coronary heart disease. 2.: Shortterm reduction in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335, 827-838 (1990).
16. Curb J.D., M.H. Maxwell, K.A. Schneider, J.O. Taylor, N.B. Shulman: Adverse effects of antihypertensive medications in the Hypertension Detection and Follow-up Program. Prog. Cardiovasc. Dis. 29 (Suppl. 1), 73-78 (1986).
17. Dahlof B., L.H. Lindholm, L. Hansson et al.: Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338, 1281-1285 (1991).
18. Edmonds C.J., B. Jasoni: Total body potassium in hypertensive patients during prolonged diuretic therapy. Lancet 11, 8-11 (1972).
19. Eknoyan G.: Understanding diuretic therapy. Drug Ther. 11, 47-58 (1981).
20. Fajans S.S., J.C. Floyd, R.F. Knopf, J. Rull, E.M. Guntsche, J.W. Conn: Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man. J. Clin. Invest. 45, 481-502 (1966).
21. Felson D.T., D. Sloutskis, J.J. Anderson, J.M. Anthony, D.P. Kiel: Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. J. Am. Med. Ass. 265, 370-373 (1991).
22. Ferranini E., B. Giuseppe, R. Bonadonna, M.A. Giorico, M.A. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, S. Bevilacqua: Insulin resistance in essential hypertension. N. Engl. J. Med. 317, 350-357 (1987).
23. Freis E.D.: The cardiovascular risks of thiazide diuretics. Clin. Pharmacol. Ther. 39, 239-243 (1986).
24. Freis E.D., R.F. Sappington: Long-term effect of probenecid on diuretic-induced hyperuricemia. JAMA 198, 147-149 (1966).
25. Freis E.D., V. Papademetrion: How dangerous are diuretics? Drugs 30, 469-474 (1985).
26. Full M., S.-M. Shieh, D.-A. Wu, Y.D. Chen, G.M. Reaven: Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch. Intern. Med. 147, 1035-1038 (1987).
27. Gabow P.A., S. Moore, R.W. Schrier: Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann. Intern. Med. 90, 338-340 (1979).
28. Goldman A.I., B.W. Steele, H.W. Schnaper, A.E. Fitz, E.D. Frohlich, H.M. Perry: Serum lipoprotein levels during chlorthalidone therapy. JAMA 244, 1691-1695 (1980).
29. Grantham J.J., A.M. Chonko: The physiological basis and clinical use of diuretics. In: Brenner B.M., J.H. Stein: Sodium and water homeostasis. Churchill Livingstone, New York 1978, 178-211.
30. Grcenblatt D.J., J. Koch-Weser: Adverse reactions to spironolactone. J. Am. Med. Ass. 225, 40-43 (1973).
31. Grimm R.H., A.S. Leon, D.B. Hunninghake, K. Lenz, P. Hannan, H. Blackburn: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double blind controlled trial. Ann. Int. Med. 94, 7-11 (1981).
32. Grimm R.H., J.D. Cohen, W.M. Smith, L. Falvo-Gefard, J.D. Neaton: Hypertension management in the Multiple Risk Factor Intervention Trial (MRFTT). Six-year intervention results for men in special intervention and usual care groups. Arch. Intern. Med. 145, 1191-1199 (1985).
33. Heath W.C., E.D. Freis: Triamterene with hydrochlorothiazide in the treatment of hypertension. J. Am. Med. Ass. 186, 119-122 (1963).
34. Helderman J.H., D. Elahi, D.K. Andersen, G.S. Raizes, J.D. Tobin, D. Shocken, R. Andres: Prevention of glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32, 106-111 (1983).
35. Hollifield J.W.: Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am. J. Med. 77, 28-32 (1984).
36. Hollifield J.W., P.E. Slaton: Thiazide diuretics, hypokalemia, and cardiac arrhythmia. Acta Med. Scand. 1 (Suppl. 647), 67-73 (1981).
37. Hollifield J.W.: Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium and ventricular ectopy. Am. J. Med. 80 (Suppl. 4A), 8-12 (1986).
38. Iseri L.T., J. Freed, A.R. Bures: Magnesium deficiency and cardiac disorders. Am. J. Med. 58, 837-846 (1975).
39. Kannel W.B., W.P. Castelli, T. Gordon: Cholesterol in the prediction of atherosclerotic disease. Ann. Intern. Med. 90, 85-91 (1979).
40. Kaplan N.M.: Problems with the use of diuretics in the treatment of hypertension. Am. J. Nephrol. 6, 1-5 (1986).
41. Kaplan N.M.: Clinical hypertension, 5th ed. Williams and Wilkins, Baltimore 1990, 194.
42. LaCroix A.Z., J. Wienpahl, L.R. White, R.B. Wallace, P.A. Scherr, L.K. George, J. Cornoni-Huntley, A.M. Ostfeld: Thiazide diuretic agents and the incidence of hip fracture. N. Engl. J. Med. 322, 286-290 (1990).
43. Lardinois C.K., S.L. Neuman: The effect of antihypertensive agents on serum lipids and lipoproteins. Arch. Intern. Med. 148, 1280-1288 (1988).
44. Lasser N.L., G.W. Grandits, A.W. Caggiula, J.A. Cutter, R.H. Grimm, L.H. Kuller, R.W. Sherwin, J. Stamler: Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am. J. Med. 76 (Suppl. 2A), 51-65 (1984).
45. Leren P.: Effects of antihypertensive drugs on lipid metabolism. Clin. Ther. 9, 326-332 (1987).
46. Levine D.Z., D. Page: Diuretic-induced acid-base disturbances. In: Dirks J.H., R.A.L. Sutton: Diuretics: Physiology, pharmacology and clinical use. Saunders, Philadelphia 1986, 320-340.
47. Lipid Research Clinics Primary Prevention Trial Results: II. Relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J. Am. Med. Ass. 144, 1947-1953 (1984).
48. Magee P.F.A., E.D. Freis: Is low-dose hydrochlorothiazide effective? Hypertension 8 (Suppl. II). II135-II139 (1986).
49. Materson B.J., J.R. Oster, U.F. Michael, S.M. Bolton, Z.C. Burton, J.E. Stambaugh, J. Morledge: Dose response to chlorthalidone in patients with mild hypertension: efficacy of a lower dose. Clin. Pharmacol. Ther. 24, 192-198 (1978).
50. McInnes G.T., W.W. Yeo, L.E. Ramsay, M. Moser: Cardiotoxicity and diuretics: much speculation - little substance. J. Hypertens. 10, 317-335 (1992).
51. Medical Research Council Working Party on Mild to Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 11, 539-542 (1981).
52. Melby J.C.: Selected mechanisms of diuretic-induced electrolyte changes. Am. J. Cardiol. 58, 1A-4A (1986).
53. Messerli F.H., E.D. Frohlich, G.R. Dreslinski, D.H. Suarez, G.E. Aristimuno: Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann. Int. Med. 93, 817-821 (1980).
54. Meyer-Lehnert H., R.W. Schrier: Hyponatremia: diagnosis and treatment. In: Seldin D.W., G. Giebisch: The regulation of sodium and chloride balance. Raven, New York 1990, 433-456.
55. Middeke M., P. Weisweiler, P. Schwandt, H. Holzgreve: Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics. A controlled long-term comparative trial. Clin. Cardiol. 10, 94-98 (1987).
56. Middeke M., W.O. Richter, P. Schwandt, B. Beck, H. Holzgreve: Normalisation of lipid metabolism after withdrawal from antihypertensive long-term therapy with beta-blockers and diuretics. Arteriosclerosis 10, 145-147 (1990).
57. Morgan D.B., C. Davidson: Hypokalemia and diuretics: an analysis of publications. Br. Med. J. 280, 905-908 (1980).
58. Moser M., M.D. Blanfox, E. Freis, R.W. Gifford, W. Kirkendall, H. Langford, A. Shapiro, S. Sheps: Who really determines your patient's prescriptions. J. Am. Med. Ass. 265, 498-500 (1991).
59. Moser M.: Effect of diuretics on morbidity and mortality in the treatment of hypertension. Cardiology 84 (Suppl. 2), 27-35 (1994).
60. Moser M.: In defence of traditional antihypertensive therapy. Hypertension 12, 324-326 (1988).
61. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal result. BMJ 304, 405-412 (1992).
62. Multicenter Diuretic Study Group: Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Arch. Intern. Med. 141, 482-486 (1981).
63. Murphy M.B., P.J. Lewis, E. Kohner, B. Schumer, C.T. Dollery: Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follw-up. Lancet 11, 1293-1295 (1982).
64. Papademetriou V., I.E. Burris, A. Notargiacoma, R.D. Fletcher, E.D. Freis: Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch. Intern. Med. 148, 1272-1276 (1988).
65. Papademetriou V., R.D. Fletcher, I.M. Khatri, E.D. Freis: Diuretic-induced hypokalemia in uncomplicated systemic hypertension: Effect of plasma potassium on cardiac arrhythmias. Am. J. Cardiol. 52, 1017-1022 (1983).
66. Ponce S.P., A.E. Jennings, N.E. Madias, J.T. Harrington: Drug-induced hyperkalemia. Medicine 64, 357-370 (1985).
67. Poulter N.B.: Thiazides and beta-blockers in hypertension: time to change. Pharm. J. 244, 626-627 (1990).
68. Ram C.V.S., B.N. Garrett, N.M. Kaplan: Moderate sodium restriction and various diuretics in the treatment of hypertension: effects of potassium wastage and blood pressure control. Arch. Intern. Med. 141, 1015-1019 (1981).
69. Ramsey L.E.: Diuretic drugs. In: Dukes M.N.G., L. Beeley: Side effects of drugs, Annual 11, Elsevier, Amsterdam 1987, 193-202.
70. Ramsay L.E., W.W. Yeo, P.R. Jackson: Metabolic effects of diuretics. Cardiology 84 (Suppl. 2), 48-56 (1994).
71. Ruppert M., J. Diehl, R. Kolloch, A. Overlack, K. Kraft, B. Göbel, N. Hittel, K.O. Stumpe: Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klin. Wochenschr. 69 (Suppl. XXV), 51-57 (1991).
72. Schoenfield M.F., E. Goldberger: Hypercholesterolemia induced by thiazides: a pilot study. Br. Ther. Res. 6, 180-184 (1964).
73. Seller R.H., J. Cangiano, K.F. Kim, S. Mendelssohn, A.B. Brest, C. Swartz: Digitalis toxicity and hypomagnesemia. Am. Heart J. 79, 57-68 (1970).
74. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J. Am. Med. Ass. 265, 3255-3264 (1991).
75. Szatalowic: V.L., P.D. Miller, J.W. Lacher, J.A. Gordon, R.W. Schrier: Comparative effect of diuretics on renal water excretion in hyponatremic edematous disorders. Clin. Sci. 62, 235-238 (1982).
76. Talso P.J., A.J. Carballo: Effects of benzothiadiazines on serum and total body electrolytes. Ann. NY Acad. Sci. 88, 975-989 (1960).
77. Tannenbaum R.J., A.R. Crosley: A comparison of the effects of hydrochlorothiazide and hydrochlorothiazide in combination with triamterene on electrolyte balance. Clin. Pharmacol. Ther. 7, 777-782 (1966).
78. Unwin R.: Chlorthalidone. In: Dollery C.T., A.R. Boobis, D.M. Burley et al.: Therapeutic drugs. Churchill Livingstone, Edinburgh 1991, C221-C224.
79. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. J. Cardiol. 52, 1230-1237 (1983).
80. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Efficacy of propanolol and hydrochlorothiazide for the initial treatment of hypertension. II.: Results of longterm therapy. J. Am. Med. Ass. 248, 2004-2011 (1982).
81. Weidmann P., A. Gerber, R. Mordasini: Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5 (Suppl. III), (1983), III120-III131.
82. Weidmann P., D.E. Uehlinger, A. Gerber: Antihypertensive treatment and serum lipoproteins. J. Hypertens. 3, 297-306 (1985).
83. Weinberger M.H.: Comparison of captopril and hyprochlorothiazide alone and in combination in mild to moderate essential hypertension. Br. J. Clin. Pharmacol. 14, 127S-131S (1982).
84. Weinberger M.H.: Antihypertensive therapy and lipids: paradoxical influences on cardiovascular risk. Am. J. Med. 80 (Suppl. 2A), 64-70 (1986).
85. Whang R., J.K. Aikawa: Magnesium deficiency and refractoriness to potassium repletion. J. Chron. Dis. 30 65-68 (1977).
86. Wilhelmsen L., G. Berglund, D. Elmfeldt et al.: Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J. Hypertens. 5, 561-572 (1987).